Is it Time to Dump Lannett Company, Inc. (LCI) Stock After it Is Lower By 39.10% in a Week?

Tuesday, April 04, 2023 01:18 PM | InvestorsObserver Analysts

Mentioned in this article

Is it Time to Dump Lannett Company, Inc. (LCI) Stock After it Is Lower By 39.10% in a Week?

Overall market sentiment has been high on Lannett Company, Inc. (LCI) stock lately. LCI receives a Bullish rating from InvestorsObserver Stock Sentiment Indicator.

Lannett Company, Inc. has a Bullish sentiment reading. Find out what this means for you and get the rest of the rankings on LCI!

See Full LCI Report

What is Stock Sentiment?

When making investment decisions, sentiment gives a good overview of what stocks investors currently favor. Sentiment incorporates short-term technical analysis into its score and does not encompass any fundamental analysis such as profitability of the company. This means that earnings updates and other news can greatly impact overall sentiment. Changes in price are generally the best indicator of sentiment for a particular stock. At its core, a stock's trend indicates whether current market sentiment is bullish or bearish. Investors must be bullish if a stock is trending upward, and are bearish if a stock is moving down. InvestorsObserver's Sentiment Indicator factors in both price changes and variations in volume. An increase in volume usually means a current trend is stengthening, while a drop in volume tends to signal a reversal to the ongoing trend. Our system also uses the options market in order to receive additional signals on current sentiments. We take into account the ratio of calls and puts for a stock since options allow an investor to bet on future changes in price.

What's Happening With LCI Stock Today?

Lannett Company, Inc. (LCI) stock is trading at $0.95 as of 1:17 PM on Tuesday, Apr 4, a decline of -$0.93, or -49.46% from the previous closing price of $1.88. The stock has traded between $0.86 and $1.85 so far today. Volume today is more active than usual. So far 725,782 shares have traded compared to average volume of 48,732 shares.

More About Lannett Company, Inc.

Lannett Co Inc develops, manufactures, packages, markets, and distributes generic versions of brand pharmaceutical products. It offers solid oral, extended-release, topical, nasal, and oral solution finished dosage forms of drugs that address a range of therapeutic areas, as well as ophthalmic, patch, foam, buccal, sublingual, soft gel, and injectable dosages. In addition, the company also provides its products for various medical indications comprising glaucoma, gastrointestinal, migraine, obesity, respiratory, and others. It operates in the segment of generic pharmaceuticals. Its customers include generic pharmaceutical distributors, drug wholesalers, chain drug stores, private label distributors, mail-order pharmacies, and others. Click Here to get the full Stock Report for Lannett Company, Inc. stock.